Lotus Pharmaceutical (1795.TW) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
0.16
1.59
3.03
4.46

Details

Expected EPS
0.164250474
Actual EPS
0.15650223
Surprise EPS
-0.01
Surprise Percent
+4.72%

Description

Lotus Pharmaceutical (1795.TW) has reported earnings of 0.15650223 per share for Q3 2024.

0 Comments

Share your thoughts